Urspeter Masche

407 total citations
25 papers, 286 citations indexed

About

Urspeter Masche is a scholar working on Surgery, Rheumatology and Molecular Biology. According to data from OpenAlex, Urspeter Masche has authored 25 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in Urspeter Masche's work include Rheumatoid Arthritis Research and Therapies (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Gastrointestinal motility and disorders (2 papers). Urspeter Masche is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Gastrointestinal motility and disorders (2 papers). Urspeter Masche collaborates with scholars based in Switzerland. Urspeter Masche's co-authors include Peter J. Meier, Karin Fattinger, Suzanne Braunschweig, Małgorzata Roos, Renato L. Galeazzi, Théo Gasser, Gerd A. Kullak‐Ublick, Ferenc Folláth, Katharina Rentsch and A. von Felten and has published in prestigious journals such as Anesthesia & Analgesia, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Urspeter Masche

7 papers receiving 265 citations

Peers

Urspeter Masche

TOXIC

GG

PPCH

PHARM

Lateef M. Khan Saudi Arabia

A Hoffmann Germany

Katrin Farker Germany

TJ White United States

Parvati B. Patel India

Sabine Krebs Germany

Tanya Azaz‐Livshits Israel

Cecilia Biriell Sweden

Supriya Malhotra India

J Vénulet Switzerland

Lateef M. Khan Saudi Arabia

Urspeter Masche

142 ×1.2

TOXIC

119 ×1.1

GG

91 ×1.0

PPCH

43 ×1.0

PHARM

28 ×0.7

PHARM

Citations per year, relative to Urspeter Masche Urspeter Masche (= 1×) peers Lateef M. Khan

Countries citing papers authored by Urspeter Masche

Since Specialization

Citations

This map shows the geographic impact of Urspeter Masche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urspeter Masche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urspeter Masche more than expected).

Fields of papers citing papers by Urspeter Masche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urspeter Masche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urspeter Masche. The network helps show where Urspeter Masche may publish in the future.

Co-authorship network of co-authors of Urspeter Masche

This figure shows the co-authorship network connecting the top 25 collaborators of Urspeter Masche. A scholar is included among the top collaborators of Urspeter Masche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urspeter Masche. Urspeter Masche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Masche, Urspeter. (2020). Upadacitinib. 41(12).

2.

Masche, Urspeter. (2015). Probiotika. 36(online).

3.

Masche, Urspeter. (2014). Behandlung der Osteoporose. 36(10).

4.

Masche, Urspeter. (2013). Linaclotid. 35(9).

5.

Masche, Urspeter. (2012). Bilastin. 34(4).

6.

Masche, Urspeter. (2011). Golimumab. 32(18).

7.

Masche, Urspeter. (2009). Hormone gegen das Altern. 31(9).

8.

Masche, Urspeter. (2008). Monovalenter Rotavirus-Impfstoff. 30(10).

9.

Masche, Urspeter. (2007). Zonisamid. 29(10).

10.

Masche, Urspeter. (2005). Ximelagatran/Melagatran. 27(1).

11.

Masche, Urspeter. (2004). Gefitinib. 26(8).

12.

Masche, Urspeter. (2003). Lichttherapie bei Depressionen. 24(12).

13.

Fattinger, Karin, et al.. (2002). No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients. European Journal of Clinical Pharmacology. 57(12). 863–867. 13 indexed citations

14.

Masche, Urspeter. (2002). Basistherapie der rheumatoiden Arthritis. 24(3).

15.

Masche, Urspeter. (2001). Reboxetin. 23(3).

16.

Masche, Urspeter. (2000). Gelenk- und Knocheninfektionen. 21(11). 5 indexed citations

17.

Fattinger, Karin, Małgorzata Roos, Urspeter Masche, et al.. (2000). Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. British Journal of Clinical Pharmacology. 49(2). 158–167. 223 indexed citations

18.

Masche, Urspeter, Katharina Rentsch, A. von Felten, Peter J. Meier, & Karin Fattinger. (1999). No clinically relevant effect of Iornoxicam intake on acenocoumarol pharmacokinetics and pharmacodynamics. European Journal of Clinical Pharmacology. 54(11). 865–868. 30 indexed citations

19.

Masche, Urspeter, Katharina Rentsch, A. von Felten, Peter J. Meier, & Karin Fattinger. (1999). Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics. European Journal of Clinical Pharmacology. 54(11). 857–864. 10 indexed citations

20.

Masche, Urspeter. (1989). Systemische Nebenwirkungen von Augentropfen. 11(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact